机构：[1]Faculty of Life Science and Technology, Kunming University of Science and Technology[2]Medical School, Kunming University of Science and Technology[3]Department of Medical Genetics, NHC Key Laboratory of Preconception Health Birth in Western China, Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases, First People’s Hospital of Yunnan Province, Affliated Hospital of Kunming University of Science and Technology
第一作者机构：[1]Faculty of Life Science and Technology, Kunming University of Science and Technology[2]Medical School, Kunming University of Science and Technology
共同第一作者：
通讯作者：
通讯机构：[1]Faculty of Life Science and Technology, Kunming University of Science and Technology[2]Medical School, Kunming University of Science and Technology[3]Department of Medical Genetics, NHC Key Laboratory of Preconception Health Birth in Western China, Yunnan Provincial Key Laboratory for Birth Defects and Genetic Diseases, First People’s Hospital of Yunnan Province, Affliated Hospital of Kunming University of Science and Technology
推荐引用方式(GB/T 7714)：
Dong-Ling Cai,Ying Chan,Ya-Min Kong,et al.Ginsenoside Rg1 promotes fetal hemoglobin production in vitro: A potential therapeutic avenue for β-thalassemia[J].European Journal of Pharmacology.2024,968:doi:doi.org/10.1016/j.ejphar.2024.176404.
APA：
Dong-Ling Cai,Ying Chan,Ya-Min Kong,Yi-Ze Liu,Yan Guo...&Bao-Sheng Zhu.(2024).Ginsenoside Rg1 promotes fetal hemoglobin production in vitro: A potential therapeutic avenue for β-thalassemia.European Journal of Pharmacology,968,
MLA：
Dong-Ling Cai,et al."Ginsenoside Rg1 promotes fetal hemoglobin production in vitro: A potential therapeutic avenue for β-thalassemia".European Journal of Pharmacology 968.(2024)
